Overall, the simulator is intended as a testbed for extensive comparisons of myocardial motion tracking methods due to its ability to relate the impaired myocardial function with the associated ventricular remodeling, a novel contribution in the literature of cardiac image simulators.
Since there is no evidence for catalytic inhibition of mTOR by EtOH, the prototypical allosteric inhibitor, rapamycin, was used for extensive comparisons.
There are also opportunities for extensive comparison of DMFT data across more LAC countries, with a focus on the elderly.
For more extensive comparisons, the ratios from an earlier investigation undertaken by the authors and co-workers and those from other researchers were also included for discussion.
Roberts: No Orman: No. Learn more about the candidates: For more extensive comparisons, see articles in the Wichita Eagle and Lawrence Journal World Roberts Pat Roberts Vote Smartt pages and Pat Roberts On the Issues pages Orman: Greg Orman Vote Smart pages and Greg Orman On the Issues pages.
They gave extensive comparisons for object recognition tasks based on the theoretical analysis of max pooling and average pooling.
The goal of this study is not to compare the power of individual fingerprints; see Sastry [28] for an extensive comparison.
(For an extensive comparison and benchmarking, see the [22].) Note that SignaLink uses more than 20 reviews per each pathway to list pathway components, in contrast to the average 5 15 reviews per a pathway in other resources [22].
For more extensive comparison of other static clustering methods we refer to our previous studies, which identified HAC-ML as the best-performing link-prediction method for large networks, including cluster-free link prediction by graph diffusion kernels (Park and Bader, 2011).
All these predictions are challenged through extensive comparisons with measurements for multipole moments, moments of inertia, spin and shape isomers as well as superdeformed phonons, inner and outer potential barrier heights, and shape isomer lifetimes.
The value of comparative clinical trials for showing clinical equivalence of biosimilars that demonstrate a high degree of similarity in physical, chemical, structural, and biological characteristics with the original product is increasingly being questioned, and advances in analytical methods that provide robust non-clinical data might reduce the need for extensive clinical comparisons.
